Upcoming presentations
Steffen Meyer (Ethris): Strengthening the First Line of Defense: Mucosal IFN-mediated prevention of respiratory viral infections
KIT Kongresse - Kongress für Infektionskrankheiten und Tropenmedizin, Köln
30 Jun 2026
Carsten Rudolph (Ethris): Designing systems for pandemic and technological resilience in Europe (9:30 am) & Spotlight Bavaria: Driving success for biotech startups (1:45 pm)
Bay-O-Connect, Munich
21 Jul 2026
Carsten Rudolph (Ethris): CEO & mRNA Leaders Think Tank: From CAR-T Platforms, Gene Editing Triumphs & Cancer Immunotherapy Clinical Advances; Navigating mRNA’s Potential into New Therapies & Tools Towards Better Drugs for Patients Faster
mRNA-Based Therapeutics Summit, Boston MA
22 Jul 2026
Carsten Rudolph (Ethris): Development of mRNA Therapeutics for the Prevention & Treatment of Respiratory Diseases
mRNA-Based Therapeutics Summit, Boston MA
Past presentations
03 Jun 2026
Steffen Meyer (Ethris): “Research to policy action” dialogue: Broad-spectrum antiviral therapeutics for pandemic preparedness"
Brussels